Key Links:
By Topic:
Search:
CROI 2005: Index of Coverage
Complications of HIV/HAART
- Odds and Ends From CROI 2005: CD4+ Testing, Enfuvirtide Site Reactions, Erectile Dysfunction and Cancers (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Body Shape, Lipids and Cardiovascular Disease at CROI (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Severity and Rate of Abacavir Hypersensitivity Reactions Higher Than Previously Believed (February 23, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Developing World
- Uganda's Decline in HIV/AIDS Prevalence Attributed to Increased Condom Use, Early Death From AIDS, Study Says (February 24, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Drug Resistance
- K65R Mutation Revealed in 4 Non-Responders to Abacavir + Lamivudine + Tenofovir Failed Regimen -- Significance Unclear (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - No Difference Seen in Resistance Profiles of Emtricitabine and Lamivudine (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Sequencing and 2 of the Most Popular Backbone Regimens (February 25, 2005)
A comparison of resistance mutations with abacavir + lamivudine versus tenofovir + lamivudine.
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Epidemiology
- HIV Treatment: 2 Million Years of Life Saved in U.S. (March 1, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - First Human HTLV Cases Discovered in Cameroon (February 28, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - HIV Prevalence Among U.S. Blacks Was 2.14% in 2001, CDC Says (February 28, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - In New York City, Unsafe Sex More Likely Among HIV-Infected Women Than HIV-Infected Gay or Heterosexual Men (February 28, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Researchers Still Divided Over Significance of New York City Case of Rare, Drug-Resistant HIV Strain (February 25, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Probable Acquisition of Multi-Drug-Resistant HIV in Man With Subsequent Rapid HIV Disease Progression: Reality and Reaction (February 24, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
New Antiretrovirals
- Ritonavir-Boosted Tipranavir Update at CROI 2005 (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - TMC-114 Sets a New Standard in Salvage Therapy Trials (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Safety and Pharmacokinetic Data for 640385, a New Protease Inhibitor in Development (February 24, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Pathogenesis
- Scientists Discover a Key to How AIDS Virus Attacks the Body (February 24, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Pharmacokinetics
- CNS Penetration of Antiretroviral Agents May Not Be Essential for Prevention of AIDS-Related Dementia (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - New Research Explores Potential Value of Therapeutic Drug Monitoring (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - The Relevance of Host Genotype on Nevirapine Drug Levels (February 23, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Prevention
- Microbicide Pilot Study Shows Promise in Women (March 9, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Treatment-Naive Patients
- Acute HIV Infection: A Unique Opportunity to Intervene (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Fixed-Dose Pill of Abacavir/Lamivudine Taken Once a Day Is Comparable to Twice-a-Day Abacavir + Lamivudine (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Multi-National Trial Confirms Superiority of 3-Drug Regimen Containing Efavirenz for the Treatment Naive (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Abacavir Is Not Associated With the Metabolic Changes Seen in Patients Treated With Stavudine (February 24, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - EuroSIDA Study Confirms Ability of Most HAART Regimens to Decrease Rates of Illness and Death (February 24, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Meta-Analysis of Triple-Combination Therapy in Treatment-Naive Patients (February 24, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Mortality Unaffected by Initial HAART Regimen Choice (February 24, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Treatment Switching/Simplification
- Comparing a Treatment Interruption With or Without Interleukin-2 in Delaying a Falling CD4+ Cell Count (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Dual NRTI Plus Efavirenz Regimen Superior to Boosted PI Plus Efavirenz (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Strategies for Switching and Simplifying Antiretroviral Treatment in HIV-Infected Patients: Part I: Research Update (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Strategies for Switching and Simplifying Antiretroviral Treatment in HIV-Infected Patients: Part II: Case Studies (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Women and HIV/HAART
- Combination Therapy Might Be Better Choice Than Nevirapine Alone to Prevent Vertical HIV Transmission, Researchers Say (February 25, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Problems With Drug Resistance Persist in the Prevention of Mother-to-Child Transmission in the Developing World (February 24, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Cervical and Anal Dysplasia in Women, Not Gone and Not Forgotten (February 24, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Gender and Age Differences in HIV Care and Treatment? Two Studies Note Few Differences (February 24, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
  |